Hot News

Hearing for the Investigation concerning Türk Philips Ticaret A.Ş. to be Held on August 17, 2021 (12.7.2021) 13.7.2021
The investigation conducted in response to the claim that Türk Philips Ticaret A.Ş. violated the Act no 4054 on the Protection of Competition by means of not providing the password and activation necessary for the repair and maintenance of the medical imaging devices to the applicant reached the hearing stage.  The hearing will be held on August 17, 2021 at 10:30 AM.    In accordance with the "Communiqué on Hearings Held before the Competition Board", complainants and third parties who want to...
Read
Investigation about Sahibinden Bilgi Teknolojileri Paz. ve Tic. AŞ Concluded (12.7.2021) 13.7.2021
The investigation, which was conducted in response to the claim that Sahibinden Bilgi Teknolojileri Paz. ve Tic. AŞ abused its dominant position in the market for online platform service for renting/selling vehicles and real estate by means of excessive pricing after the Board Decision dated 01.10.2018 and numbered 18-36/584-285 was annulled by the decision of Ankara 6th Administrative Court dated 18.12.2019 and numbered 2019/946 E. 2019/2625 K., was concluded. As a result of the discussion...
Read
E-Marketplace Sector Inquiry Preliminary Report Workshop" organized with the participation of stakeholders (6.7.2021) 13.7.2021
The problems that the sector faces and proposals for solution were evaluated in all aspects in the workshop concerning the e-marketplace sector organized by the Competition Authority.  The workshop, which was held in Bilkent Hotel and Congress Center campus in accordance with the social distance rules, with broad participation, started with the opening speech of the President of the Competition Authority, Birol Küle. In his speech, Küle pointed out that digitalization stands out as an importan...
Read
ANNOUNCEMENT (24.6.2021) 6.7.2021
The Board makes evaluations and takes decisions about merger and acquisition transactions upon the parties’ application to the Authority. The parties may make an application during the negotiation process concerning the merger/acquisition transaction. Within this scope, the parties may request confidentiality taking into account the possibility that the transaction may not be realized. However, the Board announces its reasoned decision prepared following the decision on our web site under any ci...
Read
Investigation regarding Deva Holding A.Ş., Gül Ecza Deposu Sanayi ve Ticaret A.Ş., Haver Farma İlaç A.Ş. and Sonuç Ecza Deposu A.Ş. Concluded (2.7.2021) 6.7.2021
The investigation conducted in response to the claim that medicine manufacturers and tender pharmaceutical warehouses violated the Act no 4054 on the Protection of Competition by colluding and by means of practices for price fixing and overpricing in selling medicine to hospitals was concluded.   As a result of the discussion of the contents of the file on 01.07.2021, the Competition Board decided that Among the investigated undertakings, Undertakings titled Gül Ecza Deposu Sanayi ve...
Read
Investigation concerning Biopharma Logistics Uluslararası Taşımacılık Sanayi ve Ticaret A.Ş., Transorient Uluslararası Taşımacılık ve Ticaret A.Ş. and Tunaset Biofarma Lojistik Hizmetleri A.Ş. (3.6.2021) 6.7.2021
The Competition Board  concluded the preliminary inquiry conducted in response to the application with the claim that biopharma logistics undertakings titled Biopharma Logistics Uluslararası Taşımacılık Sanayi ve Ticaret A.Ş., Transorient Uluslararası Taşımacılık ve Ticaret A.Ş. and Tunaset Biofarma Lojistik Hizmetleri A.Ş., which carry out qualified local and international door-to-door transportation services for the health sector, violated article 4 of Act no 4054 on the Protection of Competit...
Read
Investigation concerning Biopharma Logistics Uluslararası Taşımacılık Sanayi ve Ticaret A.Ş., Transorient Uluslararası Taşımacılık ve Ticaret A.Ş. and Tunaset Biofarma Lojistik Hizmetleri A.Ş. (3.6.2021) 6.7.2021
The Competition Board  concluded the preliminary inquiry conducted in response to the application with the claim that biopharma logistics undertakings titled Biopharma Logistics Uluslararası Taşımacılık Sanayi ve Ticaret A.Ş., Transorient Uluslararası Taşımacılık ve Ticaret A.Ş. and Tunaset Biofarma Lojistik Hizmetleri A.Ş., which carry out qualified local and international door-to-door transportation services for the health sector, violated article 4 of Act no 4054 on the Protection of Competit...
Read
Investigation concerning Unilever Sanayi ve Ticaret Türk A.Ş. Concluded (22.3.2021) 25.3.2021
The investigation conducted in response to the claim that Unilever Sanayi ve Ticaret Türk A.Ş. violated articles 4 and 6 of the Act no 4054 through actual exclusivity by preventing the sale of competing products at final sales points via various practices was concluded. As a result of the discussion of the contents of the file on 18.03.2021, the Competition Board decided that Unilever Sanayi ve Ticaret Türk A.Ş. violated articles 4 and 6 of the Act no 4054; thus the said undertaking shall be ...
Read
Investigation concerning Arnica Pazarlama A.Ş. Initiated (19.3.2021) 24.3.2021
The Competition Board concluded the preliminary inquiry conducted upon the claim that Arnica Pazarlama A.Ş. violated article 4 of the Act by preventing its authorized sellers from making sales on the internet, intervening to sales prices and imposing territory or customer restrictions.  After discussing the information and documents obtained and observations made during the preliminary inquiry in its meeting of 04.03.2021, the Competition Board concluded that the findings were significant and...
Read
Acquisition of Willis Towers Watson Public Limited Company’s sole control by Aon plc. Taken under Final Examination (22.3.2021) 24.3.2021
The Competition Board has taken the application regarding the acquisition of Willis Towers Watson Public Limited Company’s sole control by Aon plc. under final examination with its decision dated 25.02.2021 and numbered 21-10/132-M.       As it is known, the Competition Board is in charge of monitoring mergers and/or acquisitions which would result in significant lessening of efficient competition in markets according to article 7 of the Act no 4054 on the Protection of Competition. The Board...
Read